Please provide your email address to receive an email when new articles are posted on . The FDA granted de novo classification to the SeCore CDx HLA Sequencing System for use as a companion diagnostic ...
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind®, the leader in comprehensive genetics and digital mental health services, has pioneered a new level of specificity and accuracy for cheek swab-based ...
GERMANTOWN, Md. and HILDEN, Germany, June 17 /PRNewswire-FirstCall/ -- QIAGEN (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has entered into ...
CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device ...
DUBLIN, March 18, 2020 /PRNewswire/ -- The "HLA Typing Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent), Application (Cancer Research, Infectious & Non Infectious ...
Deal includes assets, infrastructure, and sales team related to the Olerup SSP line. LinkMed is taking over distribution rights to Qiagen’s Olerup SSP® product line, which consists of genomic HLA ...
ShardaCare Healthcity, a leading super-speciality hospital in Greater Noida, renowned for its advanced clinical capabilities and patient-centric approach, is organising a bone marrow transplant (BMT) ...
QIAGEN has announced that it has entered into an agreement with the Dutch molecular diagnostic component supplier Genome Diagnostics which covers the development and commercialization of 6 new tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results